MktsMarkets

Biomerica, Inc.
NASDAQ: BMRAKey statistics
BMRA News
Stories mentioning BMRA from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Feb 28 | Q4 '25Nov 30 | Q3 '25Aug 31 | Q2 '25May 31 | Q1 '25Feb 28 | Q4 '24Nov 30 | Q3 '24Aug 31 | Q2 '24May 31 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 987.00 | 1,210 | 1,380 | 749.00 | 1,119 | 1,636 | 1,807 | 1,118 |
| Cost of Goods Sold | 1,031 | 1,159 | 956.00 | 996.00 | 1,100 | 1,199 | 1,518 | 1,095 |
| Gross Profit | (44.00) | 51.00 | 424.00 | (247.00) | 19.00 | 437.00 | 289.00 | 23.00 |
| Operating Expenses | ||||||||
| Research & Development | 178.00 | 193.00 | 212.00 | 252.00 | 217.00 | 257.00 | 297.00 | 264.00 |
| Sales General & Admin | 1,076 | 1,231 | 1,330 | 1,067 | 1,012 | 1,173 | 1,360 | 1,286 |
| Total Operating Expenses | 1,254 | 1,424 | 1,542 | 1,319 | 1,229 | 1,430 | 1,657 | 1,550 |
| Operating Income (Loss) | (1,298) | (1,373) | (1,118) | (1,566) | (1,210) | (993.00) | (1,368) | (1,527) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | (6.00) | 43.00 | ||||||
| Pretax Income | (1,304) | (1,315) | 5.00 | (1,540) | (1,167) | (953.00) | (1,312) | (1,414) |
| Tax Provision | 8.00 | 5.00 | 3.00 | 4.00 | (4.00) | (3.00) | 4.00 | 7.00 |
| Net Income (Loss) | (1,312) | (1,320) | 2.00 | (1,544) | (1,163) | (950.00) | (1,316) | (1,421) |
| Earnings Per Share (Basic) | (0.44) | (0.45) | 0.00 | (0.67) | (0.48) | (0.06) | (0.63) | (0.68) |
| Earnings Per Share (Diluted) | (0.44) | (0.45) | 0.00 | (0.67) | (0.48) | (0.06) | (0.63) | (0.68) |
| Weighted Average Shares Outstanding (Basic) | 3,010 | 2,908 | 2,639 | 2,297 | 2,398 | 2,140 | 2,103 | 2,103 |
| Weighted Average Shares Outstanding (Diluted) | 3,010 | 2,908 | 2,639 | 2,297 | 2,398 | 2,140 | 2,103 | 2,103 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About BMRA
Biomerica, Inc. (NASDAQ: BMRA) is a stock listed on the Nasdaq Stock Market under the ticker symbol BMRA. It last traded at $1.61 (Nov 6, 2026, 3:44 PM ET), unchanged on the day. That gives Biomerica a market capitalisation of $7.4M.
Over the past 52 weeks BMRA has traded between $1.45 and $2.94.
Revenue for the quarter ended Feb 28, 2026 was $987.0K; a net loss of $1.3M. Revenue was down 11.8% from $1.1M in the quarter ended Feb 28, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Feb 28, 2026 | $987.0K | -$1.3M | -132.9% |
| Nov 30, 2025 | $1.2M | -$1.3M | -109.1% |
| Aug 31, 2025 | $1.4M | $2.0K | 0.1% |
| May 31, 2025 | $749.0K | -$1.5M | -206.1% |
From Biomerica’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…